DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Moore HB, Chapman MP, Hansen K. , et al.
Elevated fibrin degradation products with low fibrinolytic activity measured by thromboelastographic in severely injured patients does not warrant tranexamic acid to improve clot strength.
JACS 2019 (e-pub ahead of print)
Access:
We do not assume any responsibility for the contents of the web pages of other providers.